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Regulation of hepatitis C virus replication via threonine
phosphorylation of the NS5A protein
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Abstract
The hepatitis C virus non-structural 5A (NS5A) protein is highly phosphorylated and plays roles in both virus genome
replication and assembly of infectious virus particles. NS5A comprises three domains separated by low complexity
sequences (LCS). Mass spectrometry analysis of NS5A revealed the existence of a singly phosphorylated tryptic peptide
corresponding to the end of LCS I and the beginning of domain II that contained a number of potential phosphorylatable
residues (serines and threonines). Here we use a mutagenic approach to investigate the potential role of three of these
threonine residues. Phosphomimetic mutations of two of these (T242E and T244E) resulted in significant reductions in virus
genome replication and the production of infectious virus, suggesting that the phosphorylation of these residues negatively
regulated virus RNA synthesis. Mutation of T245 had no effect, however when T245E was combined with the other two
phosphomimetic mutations (TripleE) the inhibitory effect on replication was less pronounced. Effects of the mutations on the
ratio of basally/hyperphosphorylated NS5A, together with the apparent molecular weight of the basally phosphorylated
species were also observed. Lastly, two of the mutations (T245A and TripleE) resulted in a perinuclear restricted localization
of NS5A. These data add further complexity to NS5A phosphorylation and suggest that this analysis be extended outwith the
serine-rich cluster within LCS I.
INTRODUCTION
Hepatitis C virus (HCV) is a globally prevalent human patho-
gen and a leading cause of liver cirrhosis and hepatocellular
carcinoma, accounting for up to 500 000 related deaths per
year [1]. Although the residual risk remains largely unknown,
recent development of potent direct acting antivirals has
allowed patients to be rapidly cured of HCV infection, with a
concomitant reduction in related hepatic complications [2].
HCV is a member of the Hepacivirus genus in the family Fla-
viviridae [3]. HCV has a positive-strand RNA genome
(~9.6 kb in length) that encodes a large polyprotein (~3000
amino acids) flanked by 5¢ and 3¢-UTRs. The polyprotein is
processed by viral and host proteases into 10 viral proteins:
core, envelope glycoproteins E1 and E2, the viroporin p7, and
the non-structural (NS) proteins NS2-NS5B [4, 5]. The struc-
tural proteins, core, E1 and E2, are essential components of
the HCV virion and necessary for viral assembly, entry and
fusion [6, 7], whereas p7 and NS2 are required for assembly
of, but do not form part of, infectious virus particles. NS3 to
NS5B are necessary and sufficient to form a membrane-asso-
ciated genome replication complex [7]. Numerous prior
studies demonstrated that HCV (mediated in particular by
NS4B and NS5A) induces extensive rearrangement of the
endoplasmic reticulum to create a membranous web, which is
essential for viral RNA replication [7–9].
NS5A (~450 amino acid) is a multi-functional phosphoprotein
that is anchored to the membranous web by an N-terminal
amphipathic helix. Despite having no identified catalytic func-
tion, NS5A plays a key role in the HCV lifecycle, and is impli-
cated in both genome replication and virus assembly. These
functions are likely mediated by protein–protein interactions.
It consists of three domains (I, II and III) that are separated by
low complexity sequences (LCS); LCS I is serine-rich and LCS
II is proline-rich (Fig. 1a) [10]. The structure of domain I has
been resolved [11–13], revealing four different dimeric
arrangements of the monomeric unit. Domain I of NS5A
exhibits high sequence homology among all HCV genotypes
whereas domains II and III exhibit a lower level of homology
[14, 15].
NS5A exists in two phosphorylated forms, distinguished by
their migration on SDS-PAGE. These are referred to as the
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basal (p56) and hyperphosphorylated (p58) species of NS5A
[16–18]. It has been proposed that phosphorylation of
NS5A may play a role in regulating its differential functions
at different stages of the virus lifecycle, for example effecting
a switch between genome replication and virus assembly.
To assess the functions of NS5A phosphorylation, we and
others have used mutational analysis and mass spectrometry
to map the target sites of phosphorylation [19–23]. These
studies have identified multiple phosphorylation sites within
the LCS I that exhibit profound multi-functional effects on
HCV lifecycle. In particular, serines (S) 222, 225 and 235
have been shown to regulate HCV genome replication [23–
26], and in a recent study, we revealed the involvement of
S225 in host protein interactions and control of the sub-cel-
lular localization of NS5A [19, 20]. A number of phosphory-
lated threonines (T) have also been identified, mainly
within the C-terminal region of NS5A. These include T348
and T360 [22, 24, 25], which are also likely to play a role in
RNA replication. It should be noted that the effect of phos-
phorylation can vary between the genotypes, and the deter-
minants for this apparent genotype-specific replication
capacity are largely unknown. This can be exemplified by
the previously identified S249 (S2221 in polyprotein num-
bering) in the genotype 1b Con1 isolate as an important
phosphorylation site [26], however, mutational analysis of
the corresponding T249 residue in JFH-1 resulted in no
phenotype.
Here, we extend our functional analysis of phosphorylation
sites within LCS I [27] to investigate the role of three previ-
ously uncharacterized threonine residues; 242, 244 and 245,
in the context of both the JFH-1 cell culture infectious virus
and a corresponding subgenomic replicon. By site-directed
mutagenesis, we show here that the phosphorylation of
T242 and T244 likely acts as a negative regulator of RNA
replication. In contrast, T245 phosphorylation alone has no
phenotype, but could partially compensate for mutations at
T242/244. We show using confocal microscopy that ablating
phosphorylation of T245 resulted in a perinuclear restric-
tion of NS5A. T245 phosphorylation appeared to contribute
to hyperphosphorylation as the T245A phosphoablatant
mutation exhibited a reduction in levels of the hyperphos-
phorylated NS5A species, further illustrating the complexity
of phosphorylation within the LCS I of NS5A.
RESULTS
Phosphorylation of threonine 242 and 244
negatively regulates HCV genome replication
We previously used mass spectrometry to identify phos-
phorylated residues in JFH-1 NS5A [27]. As well as a num-
ber of phosphorylated serines, we identified a tryptic
peptide corresponding to residues 241–273 that contained
one phosphorylated residue, however we were unable to
unambiguously identify the site of phosphorylation. As we
had also previously demonstrated that S247 and T249 muta-
tions had no phenotype in either SGR or infectious virus
[26], we focussed on the three threonine residues at the
N-terminus of the tryptic peptide – T242, 244 and 245 in
LCS I. In order to understand the possible roles of these res-
idues in the HCV lifecycle, we generated a series of point
mutations to either alanine to block phosphorylation (phos-
phoablatant) or glutamic acid to mimic phosphorylation
(phosphomimetic). As well as individual mutations, we
mutated all three threonines either to alanine (TripleA), or
glutamic acid (TripleE). These mutants were generated in
the context of both mSGR-luc-JFH-1 and mJFH-1, con-
structs that had been engineered to contain unique restric-
tion sites flanking NS5A to facilitate cloning and
mutagenesis [28]. We firstly investigated the effects of these
mutations on RNA replication. To do this in vitro tran-
scribed mutant mSGR-luc-JFH-1 RNAs were electroporated
into Huh7 cells, using an NS5B polymerase-inactive mutant
(GND) as a negative control [29]. Luciferase activity 48 h
post-electroporation (hpe) was normalized to the input
assayed at 4 h as a measure of genome replication.
As shown in Fig. 1(b), none of the phosphoablatant muta-
tions (T242A, T244A, T245A and TripleA) had any signifi-
cant effect on replication, although T242A and TripleA
exhibited a modest reduction that did not reach signifi-
cance. These data suggest that the phosphorylation of these
three threonine residues is not required for genome replica-
tion. In contrast, the phosphomimetic mutations T242E
and T244E resulted in impaired replication, exhibiting up to
100-fold reduction compared to the wild-type. In contrast,
T245E exhibited no significant defect in replication, resem-
bling the parental mSGR-luc-JFH-1. Intriguingly the Tri-
pleE mutant had a more modest, yet still significant,
phenotype, reducing replication by less than 10-fold. These
results point to roles for T242, T244 and T245 in regulating
HCV genome replication.
To investigate the potential effect of T242, 244 or 245 phos-
phorylation on production of infectious virus, in vitro tran-
scripts of either wild-type or mutant full-length mJFH-1
virus RNA were electroporated into Huh7 cells. Both intra-
cellular and extracellular infectivity was quantified by titra-
tion of either cell lysates or supernatants using the IncuCyte
ZOOM as previously described [30]. As shown in Fig. 1(c),
the results largely mirrored those seen for the SGR, all of the
mutants were able to produce infectious virus, with the only
significant reductions being observed for T242E, T244E and
to a lesser extent the TripleE mutant. We conclude that
phosphorylation of these threonine residues only affects
genome replication, not virus assembly.
Threonine phosphorylation regulates NS5A
hyperphosphorylation
By Western blot analysis NS5A exhibits two distinct phos-
phorylated species, termed the hyper- and basal-phosphory-
lated forms. We [19, 20, 25, 27], and others [21, 22], have
previously shown that hyperphosphorylation involves serine
phosphorylation within LCS I, in particular serines 235 [23]
and 225 [27], with evidence for hierarchical (or sequential)
phosphorylation across LCS I [27]. We therefore asked
whether these three threonines, that are located C-terminal
Goonawardane et al., Journal of General Virology
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Fig. 1. Mutational analysis of the role of NS5A threonines 242, 244 and 245 in the HCV lifecycle. (a) Schematic of NS5A structure
showing amino acid residues for LCS I and location of the amphipathic helix (AH). The three threonine residues are highlighted in red.
(b) Replication of threonine mutants in the context of the mSGR-luc-JFH-1. Huh7 cells were electroporated with in vitro transcripts of
the indicated mSGR-luc-JFH-1 mutants. Luciferase activity was measured at 48 h post-electroporation (hpe) and was normalized to 4
hpe. (c) In vitro transcripts of mJFH-1 containing the indicated mutations were electroporated into Huh7 cells. Intracellular and extra-
cellular infectious virus was titrated at 48 hpe by using the Incucyte-ZOOM as described [29]. Data from three independent
Goonawardane et al., Journal of General Virology
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to the LCS I serine cluster, might influence or regulate
hyperphosphorylation. As shown in Fig. 2, we were able to
detect NS5A by Western blot for all mutants apart from
T242E and T244E, most likely due to the low levels of repli-
cation exhibited by these mutants. The single alanine muta-
tions resulted in a subtle change in the migration of the
basally phosphorylated form, this was more evident for Tri-
pleA where it can clearly be seen that the basally phosphory-
lated form migrated faster than the corresponding wild-type
(Fig. 2a, b, compare lanes 1 to 8). The converse was
observed for the phosphomimetic mutations: for T245E the
basally phosphorylated form migrated slower than wild-
type, and for TripleE the two forms co-migrated and could
not be distinguished. These observations are consistent with
a role for phosphorylation of these threonine residues in
driving the hierarchical phosphorylation of serines within
LCS I. The implication is that the basally phosphorylated
NS5A can be converted into the hyperphosphorylated form
by hierarchical phosphorylation across LCS I, involving
both threonines and serines and resulting in an incremental
decrease in mobility on SDS-PAGE. Quantitative analysis
revealed only subtle differences in the ratio of basal:hyper-
phosphorylated NS5A (Fig. 2).
Threonine phosphorylation may modulate the sub-
cellular localization of HCV replication complexes
We previously observed that phosphoablatant mutations in
a subset of LCS I serines (notably S225), resulted in a peri-
nuclear restricted distribution of NS5A and other replica-
tion complex factors (e.g. NS3), exemplified by a significant
reduction in the distance of NS5A-positive punctae from
the nuclear membrane [18]. We therefore sought to deter-
mine whether a similar phenotype was evident for the thre-
onine mutants. Huh7 cells were electroporated with in vitro
transcripts of either wild-type or mutant full-length mJFH-1
virus RNA and analysed by immunofluorescence (Fig. 3a, c)
for both NS5A and NS3. As expected there was a strong co-
localization of both viral proteins (scatter plots in right-
hand images). Quantitative analysis was performed by mea-
suring the distance of NS5A from the nuclear membrane in
20 cells (Fig. 3b, d). The majority of the mutants exhibited a
wild-type distribution of NS5A and NS3, however two
mutants (T245A and TripleE) exhibited the perinuclear
restricted phenotype. This was evident in the context of
both SGR (Fig. 3a, b) and infectious virus (Fig. 3c, d). As
T245A replicated as wild-type (Fig. 1b, c) the perinuclear
restriction was not due to reduced capacity for genome rep-
lication or NS5A abundance. Although T244E was able to
replicate, albeit at low levels (Fig. 1b, c) we were unable to
detect this NS5A mutant (or NS3) by immunofluorescence,
this is consistent with the low expression levels (see Fig. 2).
We also examined the distribution of NS5A in relation to
cytoplasmic lipid droplets (LDs) (Fig. 4). For all of the
mutants NS5A could be observed in discrete locations on
the surface of LDs, with no obvious differences in the distri-
bution between the various mutants and wild-type, suggest-
ing that threonine phosphorylation does not influence the
localization of NS5A to LDs. However, of note, LDs in cells
infected with both T245A and TripleE exhibited the same
perinuclear restriction observed for in Fig. 3. This was con-
firmed by spatial analysis (Fig. 5). Thus, we conclude that
threonine phosphorylation is able to control the sub-cellular
distribution of both replication complexes and LDs.
DISCUSSION
We present here the results of a mutagenic analysis of
potential sites of threonine phosphorylation in LCS I of
HCV NS5A. Our previous mass spectrometric analysis
revealed the existence of a singly phosphorylated peptide
corresponding to residues 241–273. This peptide corre-
sponded to the C-terminus of LCS (residues 241–249) and a
short segment of domain II, and contained five potential
phosphorylated residues (T242, T244, T245, S247 and
T249). As we had previously shown no phenotype for muta-
tions of S247 and T249 [26] we focussed on the remaining
three threonines. Of note, two of these, T242 and T244, are
highly conserved in all genotypes of HCV, whereas T245 is
conserved in all but genotype 4 where it is usually substi-
tuted by alanine. Our data reveal phenotypes in either repli-
cation or the sub-cellular localization of NS5A for
mutations in all three residues – we conclude that all may
be phosphorylation sites but with different functional
outcomes.
Interestingly, phosphomimetic mutations of T242 and 244
significantly reduced genome replication whereas the corre-
sponding phosphoablatant mutations had no effect. Para-
doxically we also observed that mutation of T245 to either
alanine or glutamate had no effect on genome replication,
however when the T245E mutation was combined with
T242E and T244E (TripleE) there was a partial restoration
of replication. These data suggest that phosphorylation of
T245 can override the inhibitory effect of phosphorylation
at T242 or T244, however by itself it does not affect genome
replication. A possible explanation is that T245 phosphory-
lation disrupts the recognition of T242 or T244 by cellular
kinases.
These observations suggest that phosphorylation of T242
and/or T244 might negatively regulate HCV genome repli-
cation. The mechanism by which this might occur remains
obscure, however one could speculate that phosphorylation
of T242 or T244 could disrupt the interactions of NS5A
with cellular protein(s) required for genome replication, or
could recruit proteins that block this process. In this context
it has been proposed that NS5A phosphorylation might
drive a switch between genome replication and virus assem-
bly – given that the positive-strand genome will need to
experiments are shown and error bars represent the standard error of the mean. Significant differences are denoted by *P<0.05,
**P<0.01 or ***P<0.001.
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function as a template for both processes. However, the phe-
notypes of mutants in phosphorylation sites within LCS I
appear to be limited to effects on genome replication [26,
27]. Thus, although NS5A has been convincingly demon-
strated to function at the level of infectious virus assembly,
this is not regulated by LCS I phosphorylation. It is tempt-
ing to speculate that instead of the replication/assembly
switch discussed above, LCS I phosphorylation might
instead drive the switch between genome replication and
translation. Both of these processes will require the genome
as a template but are mutually exclusive as ribosomes and
polymerases will move in opposite directions on the RNA
template. Perhaps T242/T244 phosphorylation is involved
in this switch?
In contrast to these data, phosphorylation of serines within
LCS I has been shown to be required for genome replica-
tion. For example, the phosphomimetic S225D mutation
had no effect on genome replication whereas the corre-
sponding phosphoablatant S225A mutation reduced repli-
cation 10-fold [18, 26]. Taken together, these data thus
point to a complex regulation of NS5A function by phos-
phorylation within LCS I – individual phosphorylation
events can either negatively or positively influence genome
replication.
Analysis of the distinct phosphorylated species of NS5A
(basally and hyper-phosphorylated) by SDS-PAGE and
Western blotting revealed a further interesting observation:
for T245E and TripleE the apparent molecular weight of the
Fig. 2. Analysis of NS5A protein expression for threonine mutants. Huh7 cells were electroporated with in vitro transcripts of either
(a) mSGR-luc-JFH-1 or (b) mJFH-1 containing the indicated mutants, cells were lysed at 48 hpe and analysed by Western blot with
sheep polyclonal anti-NS5A serum or anti-actin as the loading control. Western blots were quantified using Image Studio v3.1 (LI-COR).
Data from three independent experiments are shown and error bars represent the standard error of the mean.
Goonawardane et al., Journal of General Virology
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Fig. 3. Analysis of the sub-cellular localization of NS5A and NS3. Huh7 cells were electroporated with in vitro transcripts of (a) mSGR-
luc-JFH-1 or (b) mJFH-1 wild-type (WT) or the indicated mutants, seeded onto coverslips and incubated for 48 h prior to fixation. Cells
were permeabilized and immunostained for NS5A (red panels) and NS3 (green panels). Scale bar, 20 µm. The scatter plots show the
co-localization of NS5A and NS3 (x and y axes, pixel numbers). The correlation value (r) is shown for each image. Spatial data for
NS5A were determined from 20 cells for each mutant or wild-type using the Image J software package. These data were used to
determine the distance of NS5A from the nuclear envelope. The data shown are representative of three independent experiments. Sig-
nificant difference from the control value is denoted by ****P<0.0001.
Goonawardane et al., Journal of General Virology
6
Downloaded from www.microbiologyresearch.org by
IP:  129.11.22.144
On: Mon, 27 Nov 2017 15:04:24
basally phosphorylated species was increased. We previ-
ously analysed phosphomimetic mutants of serines in LCS I
[19, 20] – our analysis revealed that the apparent molecular
weight of the basally phosphorylated NS5A species
increased as the position of the phosphomimetic residue
was shifted towards the C-terminus, so, for example, the
basally phosphorylated species of the S222D mutant was
smaller than for S238D. Data presented here suggest that
this trend continues into the potential phosphorylation sites
C-terminal to S238. We interpret this observation to pro-
pose that T245 phosphorylation may prime a hierarchical
phosphorylation cascade across LCS I. For the TripleE
mutant both species of NS5A co-migrated, further implying
that production of a hyperphosphorylated species may
require complete phosphorylation of all three threonines
together with an as yet undefined subset of serines within
LCS I.
An additional level of complexity was observed when we
analysed the sub-cellular localization of the different threo-
nine mutants. Previously we had observed that for a subset
of serine mutants (notably S225A); NS5A, together with
other components of replication complexes (e.g. NS3 and
PI4P lipids) were restricted to a perinuclear region.
Although we do not yet understand the significance of this
restriction, it was associated with a 10-fold reduction in
replication, however it did not result from the reduced rep-
licative capacity as other mutants with a similar defect
showed a wild-type distribution [19, 20]. T245A and Tri-
pleE also showed this restriction, in the latter case this was
associated with a 10-fold reduction in replication although
T245A replicated as wild-type. These data suggest that the
perinuclear restriction of NS5A phospho-mutants may
depend on multiple factors. In this context our proteomic
analysis revealed that S225A did not interact with a num-
ber of cellular proteins including nucleosome assembly
protein 1-like protein 1 (NAP1L1) and bridging integrator
1 (Bin1), furthermore when these two proteins were
depleted by siRNA the distribution of wild-type NS5A was
also restricted [20]. Future work will investigate whether
threonine mutants also abrogate binding to these (and
other) cellular proteins. In addition, it will be of interest to
determine whether phosphorylation of these threonine res-
idues has any effect on the well-characterized function of
NS5A to bind to, and activate, phosphatidylinositol
4-kinase IIIa, leading to accumulation of phosphatidylino-
sitol 4-phosphate lipids [31], a function shown to be
important for genome replication.
In conclusion, this study adds to the complex and confus-
ing picture of NS5A phosphorylation. Ultimately a full
understanding of the mechanisms and consequences of
these post-translational events will require a panel of
phosphospecific antibodies. Such reagents are available for
a subset of the serines within LCS I [21, 23, 27], and have
been informative, however there is a pressing need for
similar antisera to be generated for the threonines identi-
fied in this study.
METHODS
Plasmids
DNA constructs used were derived from the full-length
pJFH-1 virus [32] and the luciferase sub-genomic replicon
(pSGR-luc-JFH-1) [19, 29]. The mSGR-luc-JFH-1 and
mJFH-1 constructs used throughout the study contained
unique restriction sites flanking the NS5A coding sequence
[28]. Site-directed mutagenesis of NS5A was performed
with a Q5 Site-Directed Mutagenesis Kit (NEB) and correct
substitutions were confirmed by sequencing.
Cell culture
Huh7 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Sigma-Aldrich) supplemented with 10%
foetal bovine serum (FBS), 100 IU penicillin ml 1, 100 µg
streptomycin ml 1, and 1% non-essential amino acids
(NEAA) in a humidified incubator at 37

C with 5% CO2.
For virus propagation, the medium was supplemented with
25mM HEPES.
Electroporation of replicon and virus RNA
constructs
The preparation of in vitro transcripts and electroporations
for both mSGR-luc-JFH-1 and mJFH-1 were conducted as
described previously [25]. In brief, 4106 Huh7 cells in
diethyl pyrocarbonate (DEPC)–PBS were electroporated
with 3 µg of in vitro transcribed RNA using a square-wave
protocol at 260 V for 25ms. Subsequently, cells were resus-
pended in complete DMEM and seeded into either 96-well
plates (n=6) at 2.5104 cells well 1, or six-well plates (n=2)
at 4105 cells well 1.
For a luciferase-based replicon assay, cells were harvested
with passive lysis buffer (Promega) at indicated time points
of 4 and 48 hpe. Luciferase activity was determined from
96-well samples on a BMG plate reader by automated addi-
tion of 50 µl luciferase assay reagent (Promega) and total
light emission was monitored.
Virus titration
HCV infectivity was determined by titration on Huh7 cells
in a 96-well format as follows. For intracellular infectivity,
at 48 hpe cells were suspended in PBS, lysed by five repeti-
tive freeze-thaw cycles and clarified by centrifugation (2800
g for 5min). For extracellular infectivity, the corresponding
cell supernatant was also clarified by centrifugation. Sam-
ples were serially diluted twofold in complete DMEM before
addition of 100 µl to cells that had been seeded 8 h earlier at
8103 cells well 1 (final volume, 200 µl). The counting of
infected cells was automated by acquisition and analysis
using an IncuCyte ZOOM platform. The virus titre was
determined by averaging the positive cell count from three
or more adjacent counted wells that gave the corresponding
titres as described previously [30].
SDS-PAGE/Western blot
Cells were washed twice in PBS, lysed in 1x Glasgow lysis
buffer (GLB – 1% (v/v) Triton X-100, 120mM KCl,
Goonawardane et al., Journal of General Virology
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Fig. 4. Analysis of the sub-cellular localization of NS5A and LD. Huh7 cells were electroporated with either wild-type (WT) or mutant
mJFH-1 virus RNA, seeded onto coverslips and incubated for 48 h prior to fixation. Cells were permeabilized and immunostained for
NS5A (green panels), and stained with Bodipy (558/568)-C12 dye to detect LD (red panels). The scatter plots show the co-localization
of NS5A and LD (x and y axes, pixel numbers). The correlation value (r) is shown for each image. The nuclei were counterstained with
DAPI (blue). Scale bars: 20 and 4µm (insets).
Goonawardane et al., Journal of General Virology
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30mM NaCl, 5mM MgCl2, 10% (v/v) glycerol, 10mM
PIPES-NaOH, pH 7.2 with protease and phosphatase
inhibitors) and harvested by centrifugation (2800 g,
10min, 4

C) before determining and normalizing protein
concentration by BCA assay (Pierce). Following separation
by SDS-PAGE, proteins were transferred to a polyvinyli-
dene difluoride (PVDF) membrane and blocked in 50%
(v/v) Odyssey blocking (OB) buffer (LI-COR) in Tris-buff-
ered saline (TBS). The membrane was incubated with pri-
mary antibodies overnight at 4

C, followed by secondary
antibodies for 2 h at room temperature, both prepared in
25% OB buffer. Primary antibodies used were; anti-NS5A
(sheep, prepared in-house, 1 : 4000) and a-Actin (mouse,
Sigma, 1 : 10 000). Secondary antibodies were anti-sheep
(800 nm) or anti-mouse (700 nm), used at 1 : 10 000 prior
to imaging using a LI-COR Odyssey Sa infrared imaging
system. Quantification of Western blots was carried out
using Image Studio v3.1 (LI-COR) using a background
subtraction method.
Immunofluorescence and confocal microscopy
Slides for immunofluorescence were prepared as described
previously [20]. In brief, cells were washed with PBS before
fixation for 20 min in 4% (w/v) PFA, cells were subsequently
permeabilized in PBS+0.1% (v/v) Triton X-100, and blocked
with PBS-T, 5% (w/v) BSA before immunostaining with pri-
mary antibody (sheep anti-NS5A; 1 : 2000 or mouse anti-NS3;
1 : 1000). Various fluorescently conjugated secondary antibod-
ies were used at 1 : 500 (Life Technology). Nuclei were coun-
terstained with DAPI. Lipid droplets were stained using the
BODIPY(558/568)-C12 dye at 1 : 1000 (Life Technology).
Confocal microscopy images were acquired on a Zeiss
LSM880 upright microscope with Airyscan, post-acquisition
analysis was conducted using Zen software (Zen version 2015
black edition 2.3, Zeiss) or Fiji (v1.49) software [33].
Quantification of NS5A distribution
For the quantification of NS5A spatial arrangement, images
were acquired with the same acquisition parameters, but with
variable gain to ensure correct exposure. The two-dimensional
coordinates of the centroids of LD were calculated using the
Fig. 5. Analysis of NS5A and LD redistribution in infected cells. Spatial distribution of NS5A relative to LD in Huh7 cells electroporated
with in vitro transcripts of either WT, or NS5A mutant mJFH-1 RNAs. Analysis was performed on the images shown in Fig. 4. Spatial
data for NS5A were determined from 20 cells for each assay using the Image J software package. These data were used to determine
the distance of NS5A and LD from the nuclear envelope. The data shown are representative of three independent experiments. Aster-
isks indicate significant difference from the control value ****P<0.0001.
Goonawardane et al., Journal of General Virology
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Analyze Particles module of Fiji (ImageJ). The distance of
each particle to the edge of the nucleus, visualized using DAPI
stain, was looked up using a Euclidean distance map com-
puted with the Distance Transform module of Fiji and
exported as a list of distance measurements via the Analyze
Particle function. Box and whisker plots of these distance
measurements were constructed using GraphPad Prism and
compared between samples using one-way ANOVA and Bon-
ferroni-corrected post hoc t-tests.
Statistical analysis
Data sets were analysed using Student’s t-test assuming a
two-tailed, unequal variance to determine the statistical dif-
ference from wild-type (WT). n=3 or greater throughout
and *P<0.05, **P<0.01, ***P<0.001. ****P<0.0001.
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